Cytocom Inc. sell Midas
Start price
18.02.21
/
50%
€9.20
Target price
18.02.22
-
Performance (%)
-68.91%
End price
29.08.21
€2.86
Summary
This prediction ended on 29.08.21 with a price of €2.86. Midas correctly predicted massive losses of -68.91% for Cytocom Inc.. Midas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cytocom Inc. | - | - | - | - |
| iShares Core DAX® | 1,93 % | -2,11 % | 11,14 % | 59,64 % |
| iShares Nasdaq 100 | -0,18 % | -5,90 % | -0,15 % | 82,45 % |
| iShares Nikkei 225® | 7,08 % | 6,46 % | 28,83 % | 59,33 % |
| iShares S&P 500 | -0,20 % | -3,67 % | -0,10 % | 55,65 % |
Comments by Midas for this prediction
In the thread Cytocom Inc. diskutieren
Sell Cleveland Biolabs